Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
29.14
-0.26 (-0.88%)
Nov 12, 2026, 4:00 PM EST - Market closed
Cogent Biosciences Employees
Cogent Biosciences had 258 employees as of December 31, 2025. The number of employees increased by 53 or 25.85% compared to the previous year. That makes Cogent Biosciences the 24,986th largest employer in the world and 3,197th in the United States.
Employees
258
Change (1Y)
53
Growth (1Y)
25.85%
Revenue / Employee
n/a
Profits / Employee
-$1,580,136
Market Cap
5.07B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 258 | 53 | 25.85% |
| Dec 31, 2024 | 205 | 41 | 25.00% |
| Dec 31, 2023 | 164 | 26 | 18.84% |
| Dec 31, 2022 | 138 | 61 | 79.22% |
| Sep 30, 2022 | 121 | 44 | 57.14% |
| Dec 31, 2021 | 77 | 62 | 413.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 470 |
| Scholar Rock Holding | 289 |
| Edgewise Therapeutics | 133 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
COGT News
- 1 day ago - Cogent Biosciences falls -6.8% - TheFly
- 2 days ago - Cogent Biosciences Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 3 days ago - Cogent Biosciences price target raised to $56 from $55 at H.C. Wainwright - TheFly
- 7 days ago - Cogent Biosciences reports Q3 net loss ($111.4M) vs. ($80.9M) last year - TheFly
- 7 days ago - Cogent Biosciences Earnings release: Q3 2026 - Filings
- 7 days ago - Cogent Biosciences Quarterly report: Q3 2026 - Filings
- 16 days ago - Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 1 month ago - Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application - TheFly